Center-Authored Papers

Filters: Author is Carpenter, Janet S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2011
Freeman EW, Guthrie KA, Caan B, Sternfeld B, Cohen LS, Joffe H, Carpenter JS, Anderson GL, Larson JC, Ensrud KE et al..  2011.  Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.. JAMA : the journal of the American Medical Association. 305(3):267-74. Abstract
2012
Carpenter JS, Guthrie KA, Larson JC, Freeman EW, Joffe H, Reed SD, Ensrud KE, LaCroix AZ.  2012.  Effect of escitalopram on hot flash interference: a randomized, controlled trial.. Fertility and sterility. 97(6):1399-1404.e1. Abstract
2013
Joffe H, Guthrie KA, Larson J, Cohen LS, Carpenter JS, LaCroix AZ, Freeman EW.  2013.  Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network.. Menopause (New York, N.Y.). 20(3):261-8. Abstract
Sternfeld B, Lacroix A, Caan BJ, Dunn AL, Newton KM, Reed SD, Guthrie KA, Booth-Laforce C, Sherman KJ, Cohen L et al..  2013.  Design and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: The MsFLASH experience.. Contemporary clinical trials. 35(1):25-34. Abstract
Newton KM, Carpenter JS, Guthrie KA, Anderson GL, Caan B, Cohen LS, Ensrud KE, Freeman EW, Joffe H, Sternfeld B et al..  2014.  Methods for the design of vasomotor symptom trials: the Menopausal Strategies: Finding Lasting Answers to Symptoms and Health network.. Menopause (New York, N.Y.). 21(1):45-58. Abstract
Cohen LS, Joffe H, Guthrie KA, Ensrud KE, Freeman M, Carpenter JS, Learman LA, Newton KM, Reed SD, Manson JE et al..  2014.  Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial.. Menopause (New York, N.Y.). 21(4):347-54. Abstract
Sternfeld B, Guthrie KA, Ensrud KE, LaCroix AZ, Larson JC, Dunn AL, Anderson GL, Seguin RA, Carpenter JS, Newton KM et al..  2014.  Efficacy of exercise for menopausal symptoms: a randomized controlled trial.. Menopause (New York, N.Y.). 21(4):330-8. Abstract
Reed SD, Guthrie KA, Newton KM, Anderson GL, Booth-Laforce C, Caan B, Carpenter JS, Cohen LS, Dunn AL, Ensrud KE et al..  2013.  Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements.. American journal of obstetrics and gynecology. Abstract
2014
Joffe H, Guthrie KA, LaCroix AZ, Reed SD, Ensrud KE, Manson JE, Newton KM, Freeman EW, Anderson GL, Larson JC et al..  2014.  Low-Dose Estradiol and the Serotonin-Norepinephrine Reuptake Inhibitor Venlafaxine for Vasomotor Symptoms: A Randomized Clinical Trial.. JAMA internal medicine. Abstract
Newton KM, Reed SD, Guthrie KA, Sherman KJ, Booth-Laforce C, Caan B, Sternfeld B, Carpenter JS, Learman LA, Freeman EW et al..  2014.  Efficacy of yoga for vasomotor symptoms: a randomized controlled trial.. Menopause (New York, N.Y.). 21(4):339-46. Abstract
African Americans
Freeman EW, Guthrie KA, Caan B, Sternfeld B, Cohen LS, Joffe H, Carpenter JS, Anderson GL, Larson JC, Ensrud KE et al..  2011.  Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.. JAMA : the journal of the American Medical Association. 305(3):267-74. Abstract
April 2012
Carpenter JS, Guthrie KA, Larson JC, Freeman EW, Joffe H, Reed SD, Ensrud KE, LaCroix AZ.  2012.  Effect of escitalopram on hot flash interference: a randomized, controlled trial.. Fertility and sterility. 97(6):1399-1404.e1. Abstract
August 2013
Sternfeld B, Guthrie KA, Ensrud KE, LaCroix AZ, Larson JC, Dunn AL, Anderson GL, Seguin RA, Carpenter JS, Newton KM et al..  2014.  Efficacy of exercise for menopausal symptoms: a randomized controlled trial.. Menopause (New York, N.Y.). 21(4):330-8. Abstract
Center-Authored Paper
Carpenter JS, Guthrie KA, Larson JC, Freeman EW, Joffe H, Reed SD, Ensrud KE, LaCroix AZ.  2012.  Effect of escitalopram on hot flash interference: a randomized, controlled trial.. Fertility and sterility. 97(6):1399-1404.e1. Abstract
Sternfeld B, Guthrie KA, Ensrud KE, LaCroix AZ, Larson JC, Dunn AL, Anderson GL, Seguin RA, Carpenter JS, Newton KM et al..  2014.  Efficacy of exercise for menopausal symptoms: a randomized controlled trial.. Menopause (New York, N.Y.). 21(4):330-8. Abstract
Newton KM, Carpenter JS, Guthrie KA, Anderson GL, Caan B, Cohen LS, Ensrud KE, Freeman EW, Joffe H, Sternfeld B et al..  2014.  Methods for the design of vasomotor symptom trials: the Menopausal Strategies: Finding Lasting Answers to Symptoms and Health network.. Menopause (New York, N.Y.). 21(1):45-58. Abstract
Cohen LS, Joffe H, Guthrie KA, Ensrud KE, Freeman M, Carpenter JS, Learman LA, Newton KM, Reed SD, Manson JE et al..  2014.  Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial.. Menopause (New York, N.Y.). 21(4):347-54. Abstract
Freeman EW, Guthrie KA, Caan B, Sternfeld B, Cohen LS, Joffe H, Carpenter JS, Anderson GL, Larson JC, Ensrud KE et al..  2011.  Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.. JAMA : the journal of the American Medical Association. 305(3):267-74. Abstract
Citalopram
Freeman EW, Guthrie KA, Caan B, Sternfeld B, Cohen LS, Joffe H, Carpenter JS, Anderson GL, Larson JC, Ensrud KE et al..  2011.  Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.. JAMA : the journal of the American Medical Association. 305(3):267-74. Abstract
Clinical Research Division
Sternfeld B, Guthrie KA, Ensrud KE, LaCroix AZ, Larson JC, Dunn AL, Anderson GL, Seguin RA, Carpenter JS, Newton KM et al..  2014.  Efficacy of exercise for menopausal symptoms: a randomized controlled trial.. Menopause (New York, N.Y.). 21(4):330-8. Abstract
Joffe H, Guthrie KA, Larson J, Cohen LS, Carpenter JS, LaCroix AZ, Freeman EW.  2013.  Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network.. Menopause (New York, N.Y.). 20(3):261-8. Abstract
Reed SD, Guthrie KA, Newton KM, Anderson GL, Booth-Laforce C, Caan B, Carpenter JS, Cohen LS, Dunn AL, Ensrud KE et al..  2013.  Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements.. American journal of obstetrics and gynecology. Abstract
Sternfeld B, Lacroix A, Caan BJ, Dunn AL, Newton KM, Reed SD, Guthrie KA, Booth-Laforce C, Sherman KJ, Cohen L et al..  2013.  Design and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: The MsFLASH experience.. Contemporary clinical trials. 35(1):25-34. Abstract
Joffe H, Guthrie KA, Larson J, Cohen LS, Carpenter JS, LaCroix AZ, Freeman EW.  2012.  Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the Menopause Strategies: Finding Lasting Answers for Symptoms and Health Research Network.. Menopause (New York, N.Y.). Abstract
December 2013
Reed SD, Guthrie KA, Newton KM, Anderson GL, Booth-Laforce C, Caan B, Carpenter JS, Cohen LS, Dunn AL, Ensrud KE et al..  2013.  Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements.. American journal of obstetrics and gynecology. Abstract